FDA Adverse Event Injury Summary report: N

RESOLUTE INTEGRITY RX

MDR report key: 5905929 · Received August 26, 2016

Report

Report Number
9612164-2016-00912
Event Type
Injury
Date Received
August 26, 2016
Date of Event
February 10, 2015
Report Date
August 29, 2016
Manufacturer
MEDTRONIC IRELAND
Product Code
NIQ
PMA / PMN Number
P110013
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 1

(B)(4). TITLE : SUCCESSFUL ROTATIONAL ATHERECTOMY FOR A REPETITIVE RESTENOSIS LESION WITH UNDEREXPANSION OF DOUBLE LAYER DRUG-ELUTING STENTS DUE TO HEAVILY CALCIFIED PLAQUE CARDIOVASC INTERV AND THER (2016) 31:65¿69 DOI 10.1007/S12928-015-0319-3. A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 1

A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

PATIENT PRESENTED WITH 90 % RESTENOSIS OF A PREVIOUSLY DEPLOYED STENT IN THE PROX LAD LESION. THE PHYSICIAN IMPLANTED ONE RESOLUTE INTEGRITY RX DRUG ELUTING STENT TO THE TARGET LESION FOLLOWED BY POST DILATATION. INCOMPLETE DILATATION REMAINED. APPROXIMATELY SIX MONTHS LATER, 50 % STENOSIS WAS OBSERVED, AND ONE YEAR LATER, 90 % RESTENOSIS WAS PRESENT. THE CALCIFIED, DOUBLE-LAYER STENTS WERE ABLATED BY ROTATIONAL ABLATION, ALONG WITH BALLOON DILATATION AND THE IMPLANT OF 3 NON MDT STENTS..

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
560187 RESOLUTE INTEGRITY RX STENT, CORONARY, DRUG-ELUTING NIQ MEDTRONIC IRELAND

Patients

Seq Age Sex Outcome Treatment
1 72 YR Required Intervention